Treatment of refractory/relapsed adult acute lymphoblastic leukemia with bortezomib-based chemotherapy

Nine pretreated patients aged >19 years with relapsed/refractory acute lymphoblastic leukemia (ALL) were treated with a combination of bortezomib plus chemotherapy before allogeneic hematopoietic stem cell transplantation (allo-HSCT). Eight (88.9%) patients, including two Philadelphia chromosome-...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Gen Med
Asıl Yazarlar: Zhao, Junmei, Wang, Chao, Song, Yongping, Liu, Yuzhang, Fang, Baijun
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2015
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4472074/
https://ncbi.nlm.nih.gov/pubmed/26109875
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJGM.S59537
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller